Abstract LB-236: M4-3-ML2, a novel glycoengineered humanized IgG1 antibody, targeting a membrane-proximal epitope of MCSP/CSPG4 exhibits potent ADCC induction in vitro and in vivo anti-tumoral efficacy in disseminated melanoma models
Mössner, Ekkehard, Tuffin, Gerald, Colombetti, Sara, Freytag, Olivier, Moser, Samuel, Dunn, Claire, Bacac, Marina, Herter, Sylvia, Otz, Tina, Waldhauer, Inja, Fauti, Tanja, van Puijenbroek, Erwin, Nicolini, Valeria, Freimoser, Anne, Jäger, Christiane, Mundigl, Olaf, Georges, Guy, Culton, Lisa, Manigold, Tobias, Gerdes, Christian, Umana, Pablo, Klein, Christian
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Superior Efficacy of the Novel Type II, Glycoengineered CD20 Antibody GA101vs. the Type I CD20 Antibodies Rituximab and Ofatumumab
Herter, Sylvia, Waldhauer, Inja, Otz, Tina, Herting, Frank, Lang, Sabine, Nicolini, Valeria, Römmele, Michaela, Friess, Thomas, Van Puijenbroek, Erwin, Bacac, Marina, Weidner, K. Michael, Gerdes, Christian, Umana, Pablo, Klein, Christian
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article